Quantum Biopharma (QNTM) Q4 2024 Earnings
QNTM·Reported March 28, 2025·Before market open
Diluted EPS came in at $-2.89, missed the $-0.80 consensus by $2.09.
Diluted EPS
$-2.89missed by $2.09
Consensus: $-0.80
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about Quantum Biopharma's Q4 2024 earnings report.
Quantum Biopharma (QNTM) reported Q4 2024 earnings on March 28, 2025 before market open.
Quantum Biopharma reported diluted EPS of $-2.89 for Q4 2024.
EPS missed the consensus estimate of $-0.80 by $2.09.